Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 12, 2021

View Archived Issues

rVSV-deltaG-spike vaccine protects hamsters against SARS-CoV-2 challenge

Forma begins phase II/III study of FT-4202 in sickle cell disease

Viralym-M enters phase III for virus-associated hemorrhagic cystitis

Dyne reports preclinical data from DM1 program

Chinese investigators divulge EGFR inhibitors

Nanjing Greepharma patents new ARG1 inhibitors

Shanghai Institute of Materia Medica discloses PRDX1 inhibitors

Hawaii Biotech identified new botulinum neurotoxin inhibitors

DalCor initiates phase II study of dalcetrapib in patients with COVID-19

Turning Point Therapeutics describes new RET inhibitors

Antibody protects broadly against flaviviruses, without ADE

A humanized mouse HIV latency model to test HIV cure strategies

Promising data presented from global phase III study with valoctocogene roxaparvovec in hemophilia A

Identification of small-molecule HNC-0014 as a multi-targeted immunotherapy lead compound for HNSCC

New heterocyclic ring systems as a novel class of brain-penetrating V1A antagonists

Chipscreen Biosciences submits IND to the NMPA for pivotal phase III study of chiauranib in SCLC

Leishmania parasites trigger SHP-1, which acts as a negative regulator of antigen cross-presentation

Axcella provides development updates for its lead candidates

European Commission approves Roclanda ophthalmic solution

Promising data presented from phase II study of rifamycin SV-MMX in IBS-D

Gannex reports phase I data on ASC-41 supporting progression for NASH

Helsinn begins phase I/II study of oral RET inhibitor TAS-0953 in advanced solid tumors

CureVac reports NHP data on COVID-19 vaccine candidate CVnCoV

New trial investigates use of NAC for IPF

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...